MedPath
HSA Approval

NIFEDIPINE LA TABLET 60 mg

SIN11680P

NIFEDIPINE LA TABLET 60 mg

NIFEDIPINE LA TABLET 60 mg

September 24, 2001

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C08CA05

nifedipine

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Valpharma International SpA

Active Ingredients

NIFEDIPINE

60 mg

Nifedipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NIFEDIPINE LA TABLET 60 mg - HSA Approval | MedPath